Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
SMS Pharmaceuticals Limited (NSE: SMSPHARMA), ISIN INE812G01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SMSPHARMA last traded at ₹512.40 (+1.47%), with a 52-week range of ₹270.10 to ₹535.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 68.07%, FIIs 1.18%, DIIs 0.19%, mutual funds 0.00%.
EquiSense Score (ECS): 78/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.